| 
	
		| 
			
				| 
					
						| 
							
								| 
									
										| 
											
												|  
													
														| 
															
															
															 GENTAUR BVBA 
															VAT BE0473327336 
															Av. de l Armee 68 B4 
															1040 Brussels 
															BELGIUM 
															  Tel + 32 16 58 90 
															45   
															Fax + 32 16 50 90 45 
															
															
															
															 GENTAUR France SARL 
															SIRET 48423788800017
															 
															Rue Lagrange, 9 
															75005 Paris, 
															France 
															
															
															 Tel 01 43 25 01 50 
															
															Fax 01 43 25 01 60 
															
															 GENTAUR Germany 
															52074 Aachen, 
															Germany 
															
															
															
															 Tel 
															
															
															0241 40 08 90 86 
															Fax 0241 55 91 
															05 36 
															
															
															 GENTAUR 
															Pol Sp. Z.o.o. Ulica 
															Ogarna 15/19B m2 
															80-826 GDANSK  
															
															
															Tel 00 48 51 760 77 
															08  
															
															
															Fax: 00 32 16 50 90 
															45 
															
															
															
															 GENTAUR Italy 
															
															23015 Milano, Italy 
															
															
															 Tel 02 36 00 65 
															93 
															
															Fax 02 36 00 65 
															94 
															
															
															
															
															
															 Česká republika 
															Praha +420246019719
 
															
															
															
															 Danmark 
															
															
															
															
															+4569918806 
															 
															
															
															
															 Finland Helsset +358942419041
 
															
															 Ελλάς Αθήνα +302111768494
 
															
															
															
															 Ireland Dublin +35316526556
 
															
															
															
															 Luxembourg +35220880274
 
															
															 Magyarország 
															Budapest +3619980547
 
															
															
															
															 Nederland +31208080893
 
															
															
															
															 Norge 
															Oslo +4721031366
 
															
															
															
															 Österreich +43720880899
 
															
															
															
															 Sverige 
															Stockholm +46852503438
 
															
															
															
															 Schweiz Züri +41435006251
  
														 
															
															Northern America 
															 
															
															
															
															 Canada Montreal +15149077481
 
															
															
															
															 US New York +17185132983
  
														 
														
														
														
														Other Countries 
														  0032 (0)16 41 44 07
 |  |  |  |  |  |  |    |  | MicroRNA Definition & Overview:  MicroRNAs (miRNAs) are small, RNA molecules encoded in the 
genomes of plants and animals (Figure 1). These highly conserved, ~21-mer RNAs 
regulate the expression of genes by binding to the 3'-untranslated regions (3'-UTR) 
of specific mRNAs.  Although the first published description of an miRNA appeared 
ten years ago (Lee 1993), only in the last two to three years has the breadth 
and diversity of this class of small, regulatory RNAs been appreciated. A great 
deal of effort has gone into understanding how, when, and where miRNAs are 
produced and function in cells, tissues, and organisms. Each miRNA is thought to 
regulate multiple genes, and since hundreds of miRNA genes are predicted to be 
present in higher eukaryotes (Lim 2003b) the potential regulatory circuitry 
afforded by miRNA is enormous. Several research groups have provided evidence 
that miRNAs may act as key regulators of processes as diverse as early 
development (Reinhart 2000), cell proliferation and cell death (Brennecke 2003), 
apoptosis and fat metabolism (Xu 2003), and cell differentiation (Dostie 2003, 
Chen 2003). Recent studies of miRNA expression implicate miRNAs in brain 
development (Krichevsky 2003), chronic lymphocytic leukemia (Calin 2004), 
colonic adenocarcinoma (Michael 2003), Burkitt’s Lymphoma (Metzler 2004), and 
viral infection (Pfeffer 2004) suggesting possible links between miRNAs and 
viral disease, neurodevelopment, and cancer. There is speculation that in higher 
eukaryotes, the role of miRNAs in regulating gene expression could be as 
important as that of transcription factors.                                                     
 Figure 1. Transcription of miRNAs. Approximately 60% of miRNAs 
are expressed independently, 15% of miRNAs are expressed in clusters, and 25% 
are in introns.
 
 Processing:
 
 Several hundred miRNAs have been cloned and sequenced from mouse, human, 
Drosophila, C. elegans, and Arabidopsis (see www.sanger.ac.uk). Estimates 
suggest that 200–300 unique miRNA genes are present in the genomes of humans and 
mice (Lim 2003 b). The sequences of many of the miRNAs are homologous among 
organisms, suggesting that miRNAs represent a relatively old and important 
regulatory pathway (Grosshans 2002).
 Most of the genome sequences encoding miRNAs occur in areas 
of the genome that are not associated with known genes; many are found in 
fragile sites in human chromosomes (Calin 2004) and appear to be independently 
transcribed (Lagos-Quintana 2001, Lau 2001, Lee 2001, Lim 2003a, 2003b). A 
number of miRNAs, are encoded in introns of primary mRNA transcripts. Typically 
they are encoded in the same orientation as the parent transcript, indicating 
that transcription of this class of miRNA gene is driven by an mRNA promoter (Aravin 
2003, Lagos-Quintana 2003, Lai 2003, Lim 2003a). Unlike C. elegans and human, in 
Drosophila, most miRNA genes are found as clusters in the genome. There is good 
evidence that these clustered miRNA genes are expressed as multi-cistronic 
transcripts which are then processed to become mature miRNAs.  The excision and activation of active single-stranded miRNAs 
from precursor transcripts occurs through a multi-step process that is depicted 
in Figure 2, and is described below.   Figure 2 . miRNA Processing and Activity
 
 
 1. TranscriptionmiRNAs are initially expressed as part of transcripts termed primary miRNAs 
(pri-miRNAs) (Lee 2002). They are apparently transcribed by RNA Polymerase II, 
and include 5' caps and 3' poly(A) tails (Smalheiser 2003, Cai 2004). The miRNA 
portion of the pri-miRNA transcript likely forms a hairpin with signals for 
dsRNA-specific nuclease cleavage.
 2. Hairpin release in the nucleusThe dsRNA-specific ribonuclease Drosha digests the pri-miRNA in the nucleus 
to release hairpin, precursor miRNA (pre-miRNA) (Lee 2003). Pre-miRNAs appear to 
be approximately 70 nt RNAs with 1–4 nt 3' overhangs, 25–30 bp stems, and 
relatively small loops. Drosha also generates either the 5' or 3' end of the 
mature miRNA, depending on which strand of the pre-miRNA is selected by RISC 
(Lee 2003, Yi 2003).
 3. Export to the cytoplasmExportin-5 (Exp5) seems to be responsible for export of pre-miRNAs from the 
nucleus to the cytoplasm. Exp5 has been shown to bind directly and specifically 
to correctly processed pre-miRNAs. It is required for miRNA biogenesis, with a 
probable role in coordination of nuclear and cytoplasmic processing steps. (Lund 
2003, Yi 2003).
 4. Dicer processingDicer is a member of the RNase III superfamily of bidentate nucleases that 
has been implicated in RNA interference in nematodes, insects, and plants. Once 
in the cytoplasm, Dicer cleaves the pre-miRNA approximately 19 bp from the 
Drosha cut site (Lee 2003, Yi 2003). The resulting double-stranded RNA has 1–4 
nt 3' overhangs at either end (Lund 2003). Only one of the two strands is the 
mature miRNA; some mature miRNAs derive from the leading strand of the pri-miRNA 
transcript, and with other miRNAs the lagging strand is the mature miRNA.
 5. Strand selection by RISCTo control the translation of target mRNAs, the double-stranded RNA produced 
by Dicer must strand separate, and the single-stranded mature miRNA must 
associate with the RISC (Hutvagner 2002). Selection of the active strand from 
the dsRNA appears to be based primarily on the stability of the termini of the 
two ends of the dsRNA (Schwarz 2003, Khvorova 2003). The strand with lower 
stability base pairing of the 2–4 nt at the 5' end of the duplex preferentially 
associates with RISC and thus becomes the active miRNA (Schwarz 2003).
 Function:
 Virtually all of the miRNAs that have been studied in animals reduce 
steady state protein levels for the targeted gene(s) without impacting the 
corresponding levels of mRNA (Olsen 1999). The mechanism by which miRNAs reduce 
protein levels is not fully understood, but one study involving the C. elegans 
lin-4 miRNA/lin-14 mRNA pair indicates that lin-4 miRNA does not affect the 
poly(A) tail length, transport to the cytoplasm, nor entry into polysomes of the 
lin-14 mRNA (Olsen, 1999). If this observation holds true for all animal miRNAs, 
then downstream steps such as translational elongation, translational 
termination, or protein stability are likely influenced by miRNAs. Mounting 
evidence suggests that miRNAs function via a similar enzyme complex as siRNAs. 
This evidence is summarized below:
 The let-7 miRNA can associate with the RISC in vitro. This 
indicates that the structure of miRNA does not preclude it from entering the 
same complex as siRNAs (Hutvagner 2002).  Endogenous miRNAs can cause degradation of recombinant mRNAs 
with binding sites that are perfectly complementary to the expressed miRNA (Hutvagner 
2002, Zeng 2003). This implies that natural miRNAs associate with RISC in cells. 
The key feature that distinguishes an miRNA from an siRNA is non-complementarity 
between the center of the miRNA and the targeted mRNA (Doench 2003, Zeng 2002).
 Immunoprecipitation experiments with antibodies targeting 
known members of the RISC (eIF2C2, Gemin 3, and Gemin 4) recover endogenous 
let-7 (Hutvagner 2002), providing further evidence that miRNAs are indeed 
associated with RISC in cells. Plant miRNAs differ from animal miRNAs in that many plant miRNAs have perfect 
homology to their target mRNAs, and they act through the RNAi pathway to cause 
mRNA degradation (Rhoades 2002). It is likely, however, that some plant miRNAs 
base-pair imperfectly with their miRNA target sites and act via a pathway 
similar to animal miRNAs (Figure 3). In plants and yeast there is also evidence 
that miRNAs are involved in repression of transcription by guiding chromatin 
methylation.
  Figure 3 . Mode of Action of miRNAs in Plants and Animals
 
 miRNAs Often Do Not Act Alone
 A key observation made by two laboratories is that mRNAs containing multiple, 
non-overlapping miRNA binding sites are more responsive to miRNA-induced 
translational repression than those containing a single miRNA binding site (Doench 
2003, Zeng 2003). Furthermore, comparisons of repression by miRNAs bound to 2, 
4, and 6 binding sites on a reporter construct indicate that translation 
decreases with each additional site (Zeng 2003). This suggests that the 
expression of miRNA target genes can be fine-tuned in animals (and potentially 
plants) by altering the concentrations or identities of miRNAs within cells. 
This observation coupled with the predictions that many mRNAs have target sites 
for many different miRNAs suggests that gene expression in various tissues and 
cells can be greatly influenced by the miRNA populations in those cells. This 
could also explain why at least some miRNAs have such broad functionality, and 
conversely why translational control of some genes is so complex. If miRNAs 
indeed regulate the translation of, but not the stability of target mRNAs, this 
might at least partially explain why gene expression profiles based on mRNA 
analysis do not always correlate with protein expression data (Kern 2003).
 Expression & Targets:
 Like mRNAs, miRNA expression profiles appear to vary from tissue to 
tissue but are similar for identical tissues in different individuals 
(Lagos-Quintana 2002, Krichevsky 2003, Michael 2003). As would be expected, 
studies indicate that tissues in developing and mature organisms are 
characterized by unique profiles of miRNA expression. Comparisons of embryonic 
stem cells and differentiated cells revealed that miRNA expression profiles 
change during differentiation (Houbaviy 2003). Notably, at least four miRNAs are 
expressed at relatively high levels prior to differentiation but are not 
expressed at all in differentiated cells.
 The mirVana™ miRNA Probe Set and mirVana™ miRNA Labeling Kit 
were used to compare the miRNA expression profiles of 25 human tissues (Figure 
4). As expected, miRNA expression profiles vary from tissue to tissue 
(Lagos-Quintana 2002, Krichevsky 2003, Michael 2003). Interestingly, miRNA 
profiles are similar between related tissues and distinct between unrelated 
tissues. For instance, heart and skeletal muscle profiles are very similar, 
digestive tract tissues cluster, and reproductive organ tissues are similar 
(Figure 4). The brain miRNA profile, however, is clearly distinct from the other 
tissues that were analyzed. Follow-up experiments indicated that brain sub-regions 
exhibited unique miRNA profiles that were clustered according to the relatedness 
of the sub-regions. The expression data suggest that miRNAs are important 
factors in differentiating tissues in adult organisms.   Figure 4 . Data Obtained with the miRNA Expression System
 
 The miRNA expression profiles (y axis) of 20-25 different human normal tissues 
(x axis) were compared to a pool of all samples in the experiment. Green in the 
heat map shows miRNAs that are down-regulated in the sample relative to the 
pool, and red shows miRNAs that are up-regulated in the sample relative to the 
pool.
 
 
 The mirVana miRNA Probe Set and mirVana miRNA Labeling Kit 
were also used to compare the expression profiles of tumor and non-tumor samples 
from individual cancer patients. Interestingly, a number of miRNAs appear to be 
routinely under- or over-expressed in tumors. For instance miR-126, miR-143, and 
miR-145 were expressed at significantly lower levels in more than 80% of the 
tumor samples compared to their associated normal tissues. miR-21 was found to 
be over-expressed in 80% of the tumor samples. These miRNAs likely represent 
biomolecules that directly or indirectly influence oncogenesis. In addition, 
several miRNAs were found to be differentially expressed in specific types of 
cancers, suggesting that there are disease-specific miRNAs.  These studies are significant because they show that tissue 
and cell samples can be defined by their miRNA expression profiles. Categorizing 
miRNAs based on their co-regulation, or identifying miRNAs that are 
differentially expressed between different tissue or cell samples will enhance 
our understanding of miRNA and protein regulation and function. If miRNAs are 
involved in oncogenesis, inflammatory response, or other disease states, 
comparative miRNA expression studies might also reveal diagnostic markers or 
even therapeutic targets. Once the mRNA targets of miRNAs are identified, 
combining mRNA and miRNA expression profiles will provide a snapshot of genes 
being regulated at the transcriptional and translational levels and will suggest 
a more comprehensive list of genes that are important to the biological process 
being studied.  miRNA Target SitesThe expression of a large number of the predicted 200–300 human miRNA genes (this 
corresponds to 1% of the protein coding genes) has been confirmed, but the 
predicted miRNA targets remain to be identified and verified. Several groups 
have developed algorithms for identificaiton of mRNA sequences that could serve 
as target sites for known miRNAs. These algorithms take advantage of the 
observation that each of the known miRNA target sites in animals has perfect or 
near perfect homology with the first eight bases of the miRNA (Lai 2002). Since 
each of the known miRNA target sites are in the 3' UTR, algorithms also restrict 
sequence searches to the 3' UTRs of mRNAs. Another extremely important 
observation is that homology searches between two or more animal genomes with 
shared miRNAs confirms that miRNA target sites are conserved. This is a key way 
to narrow the number of putative target sites. Given that most of the miRNA 
sequences are conserved between organisms, one would expect that the miRNA 
target sites would likewise be maintained even though they lie in the typically 
poorly conserved 3' UTRs of genes. As more is learned about the mRNA targets of 
the different miRNAs, it will be possible to more accurately assess gene 
expression for a given sample by combining the profiles of mRNA and miRNA 
expression.
   |